Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer.

The Thermo Fisher Scientific Clinical Next-Generation Sequencing Division (CSD) is leading the global democratization of next-generation sequencing (NGS) to accelerate translational research and positive clinical outcomes.  The division is positioned around three core pillars including: oncology, driving focused growth in translational research that will advance into the clinic, and expanding into applied markets including reproductive health and more. With our easily-adoptable end-to-end Ion Torrent sequencing technologies running central to each of these pillars, we are turning rapid, turnkey in-house testing for decentralized community hospitals and precision diagnostics into a reality.